• 17791 Citations
  • 67 h-Index
1977 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Richard J. Gralla is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles
Antiemetics Medicine & Life Sciences
Vomiting Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Cisplatin Medicine & Life Sciences
Nausea Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Vindesine Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Publications 1977 2019

  • 17791 Citations
  • 67 h-Index
  • 266 Article
  • 19 Chapter
  • 4 Review article
  • 1 Editorial

Do we still need to study palonosetron for chemotherapy-induced nausea and vomiting? A cumulative meta-analysis

Chow, R., Aapro, M., Navari, R. M., Gralla, R. J., Chiu, N., Chiu, L., Chan, S., Popovic, M., Lam, H., Lock, M. & DeAngelis, C., Oct 1 2019, In : Critical Reviews in Oncology/Hematology. 142, p. 164-186 23 p.

Research output: Contribution to journalReview article

Antiemetics
Nausea
Vomiting
Meta-Analysis
Publication Bias

Immune Checkpoint Blockade Is Associated With Durable Responses in Pulmonary Sarcomatoid Carcinoma

Sukrithan, V., Sandler, J., Gucalp, R. A., Gralla, R. J. & Halmos, B., Jan 1 2019, (Accepted/In press) In : Clinical Lung Cancer.

Research output: Contribution to journalArticle

Tumor Burden
Immunotherapy
Carcinoma
Lung
pembrolizumab

Predictive value of PD-L1 and other clinical factors for chemoimmunotherapy in advanced non-small-cell lung cancer

Woodford, R., Loh, Y., Lee, J., Cooper, W., Marschner, I., Lewis, C. R., Millward, M., Lord, S., Gralla, R. J., Yang, J. C. H., Mok, T. & Lee, C. K., Jul 1 2019, In : Future Oncology. 15, 20, p. 2371-2383 13 p.

Research output: Contribution to journalReview article

Non-Small Cell Lung Carcinoma
Drug Therapy
Randomized Controlled Trials
Patient Selection
Disease-Free Survival
64 Citations (Scopus)

Clinical and molecular characteristics associated with survival among patients treated with checkpoint inhibitors for advanced non-small cell lung carcinoma: A systematic review and meta-analysis

Lee, C. K., Man, J., Lord, S., Cooper, W., Links, M., Gebski, V., Herbst, R. S., Gralla, R. J., Mok, T. & Yang, J. C. H., Feb 1 2018, In : JAMA oncology. 4, 2, p. 210-216 7 p.

Research output: Contribution to journalReview article

docetaxel
Non-Small Cell Lung Carcinoma
Meta-Analysis
Survival
Randomized Controlled Trials

Content validity and electronic PRO (ePRO) usability of the Lung Cancer Symptom Scale-Mesothelioma (LCSS-Meso) in mesothelioma patients

Gelhorn, H. L., Skalicky, A. M., Balantac, Z., Eremenco, S., Cimms, T., Halling, K., Hollen, P. J., Gralla, R. J., Mahoney, M. C. & Sexton, C., Feb 1 2018, (Accepted/In press) In : Supportive Care in Cancer. p. 1-10 10 p.

Research output: Contribution to journalArticle

Mesothelioma
Lung Neoplasms
Appetite
Dyspnea
Fatigue